Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting

Background: Ketamine is known to rapidly reduce depressive symptoms and suicidal ideation (SI) in patients with major depressive disorder (MDD), but evidence is limited for its acceptability and effectiveness in “real-world” settings. This case series examines serial ketamine infusions in reducing S...

Full description

Bibliographic Details
Main Authors:	Belo, S. (Author), Castel, S. (Author), Levitt, A.J (Author), Mah, L. (Author), Orser, B. (Author), Schaffer, A. (Author), Sinyor, M. (Author), Vincent, M. (Author), Williams, M. (Author), Zarate, C., Jr (Author)
Format:	Article
Language:	English
Published:	Elsevier B.V. 2018
Subjects:	adult Adult amino acid receptor blocking agent Article Canada clinical article clinical assessment comorbidity controlled study Depressive Disorder, Major double blind procedure Double-Blind Method drug administration Drug Administration Schedule drug efficacy drug safety electroconvulsive therapy Excitatory Amino Acid Antagonists female Female Hamilton Depression Rating Scale hospital admission hospital patient human Humans Infusions, Intravenous Inpatients intention to treat analysis intravenous drug administration ketamine Ketamine major depression Major depressive disorder male Male mental patient midazolam Midazolam middle aged Middle Aged Montgomery Asberg Depression Rating Scale nonhuman physical examination pilot study priority journal Psychiatric Status Rating Scales psychological rating scale randomized controlled trial self report Sheehan Disability Scale suicidal ideation Suicidal Ideation suicide Suicide tertiary care center young adult Young Adult
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting

Internet

Similar Items